clinical efficacy of Dan Hong injection in treatment of chronic pulmonary heart disease acute phase

Objective To explore the of clinical efficacy Danhong Injection to cure chronic pulmonary heart disease in acute phase. Methods Pulmonary Heart Disease 64 patients were divided into treatment group 32 cases and control group 32 cases,the two groups were given correspondingly conventional symptomatic treatment ( including oxygen,anti-inflammatory,antispasmodic,sputum,strong heart,diuretic,vasodilator, etc. ) ,the treatment group was added based on the above Danhong injection 30 ml + 5% glucose infusion 250 ml,1 / d,treatment 14 d. Results The clinical total effective rate was better than the control group ( P 0. 05) ; the treatment group significantly improved blood rheology indicators ( P 0. 01) . Conclusion Injection Danhong acute treatment of chronic pulmonary heart disease of clinical efficacy and safety is good,can effectively reduce the chronic pulmonary heart disease in patients with fluid viscosity and reduce pulmonary vascular resistance,thereby improving the cardiovascular system.